MD3773G2 - Agent for treating precancerous mucous membrane and tegument affections - Google Patents

Agent for treating precancerous mucous membrane and tegument affections

Info

Publication number
MD3773G2
MD3773G2 MDA20080148A MD20080148A MD3773G2 MD 3773 G2 MD3773 G2 MD 3773G2 MD A20080148 A MDA20080148 A MD A20080148A MD 20080148 A MD20080148 A MD 20080148A MD 3773 G2 MD3773 G2 MD 3773G2
Authority
MD
Moldova
Prior art keywords
tegument
affections
agent
mucous membrane
oil
Prior art date
Application number
MDA20080148A
Other languages
Romanian (ro)
Russian (ru)
Other versions
MD3773F1 (en
Inventor
Ион МЕРЕУЦЭ
Владимир КАРАУШ
Диана ХАРШТЯ
Надежда МУНТЯНУ-ЛЕУ
Original Assignee
Ион МЕРЕУЦЭ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ион МЕРЕУЦЭ filed Critical Ион МЕРЕУЦЭ
Priority to MDA20080148A priority Critical patent/MD3773G2/en
Publication of MD3773F1 publication Critical patent/MD3773F1/en
Publication of MD3773G2 publication Critical patent/MD3773G2/en

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention refers to medicine, particularly oncology and clinical pharmacology.The agent for treating precancerous mucous membrane and tegument affections includes ricinic oil, grapestone oil, patchouly oil and holy thistle oil in the following component ratio, mass %:
MDA20080148A 2008-05-30 2008-05-30 Agent for treating precancerous mucous membrane and tegument affections MD3773G2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDA20080148A MD3773G2 (en) 2008-05-30 2008-05-30 Agent for treating precancerous mucous membrane and tegument affections

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDA20080148A MD3773G2 (en) 2008-05-30 2008-05-30 Agent for treating precancerous mucous membrane and tegument affections

Publications (2)

Publication Number Publication Date
MD3773F1 MD3773F1 (en) 2008-12-31
MD3773G2 true MD3773G2 (en) 2009-09-30

Family

ID=40255077

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20080148A MD3773G2 (en) 2008-05-30 2008-05-30 Agent for treating precancerous mucous membrane and tegument affections

Country Status (1)

Country Link
MD (1) MD3773G2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD493Z (en) * 2011-06-29 2012-10-31 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Method for prophylaxis of postradiation complications in oncological diseases
MD783Z (en) * 2013-10-08 2015-01-31 Адриан КИШКА Method for treating chronic atrophic gastritis

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Matcovschi C, Procopişin V, Parii B., Ghid farmacoterapeutic, Chişinău, 2006, p. 1287. *
Matcovschi C., Procopişin V., Parii B. Ghid farmacoterapeutic, Chişinău, 2006, p. 1287 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD493Z (en) * 2011-06-29 2012-10-31 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Method for prophylaxis of postradiation complications in oncological diseases
MD783Z (en) * 2013-10-08 2015-01-31 Адриан КИШКА Method for treating chronic atrophic gastritis

Also Published As

Publication number Publication date
MD3773F1 (en) 2008-12-31

Similar Documents

Publication Publication Date Title
MY158438A (en) Antibodies against human angiopoietin 2
IN2012DN02805A (en)
UA104005C2 (en) 2-oxo-1,2-dihydro-quinoline modulators of immune function
IN2012DN02177A (en)
IN2012DN02702A (en)
IN2012DN00754A (en)
EA201170227A1 (en) ИМИДАЗОЛКАРБОКСАМИДЫ
CY1117524T1 (en) ORIGINAL PYROLLI INHIBITORS OF S-NITROZOGLUTATHYONE PRODUCTION AS THERAPEUTIC AGENTS
TN2011000414A1 (en) Pharmaceutical composition comprising linagliptin and optionally a sglt2 inhibitors, and uses thereof
PH12013500481A1 (en) Estrogen receptor modulators and uses thereof
PH12012502419A1 (en) Estrogen receptor modulators and uses thereof
PH12013500467A1 (en) Pharmaceutical composition
MA33803B1 (en) BENZODIAZEPINE BROMODOMAINE INHIBITOR
WO2012088266A3 (en) Substituted imidazopyridazines and benzimidazoles as inhibitors of fgfr3
IN2012DN00971A (en)
IN2012DN00624A (en)
MX2012000396A (en) Methods and compositions for use in cellular therapies.
WO2010083385A3 (en) Compounds for reducing drug resistance and uses thereof
UA98839C2 (en) N,n-disubstituted aminoalkylbiphenyl antagonists of prostaglandin d2 receptors
MX2011000255A (en) Combination of a c-met antagonist and an aminoheteroaryl compound for the treatment of cancer.
IN2012DN02471A (en)
NZ589517A (en) A pharmaceutical composition comprising rebamipide
MX2010006206A (en) 5-halogen-substituted oxindole derivatives and use thereof for treating vasopressine-dependent diseases.
MX338884B (en) COMPOSITIONS AND METHODS THAT INCLUDE PROTEASA VARIATIONS.
MX2011006725A (en) Combination of aurora kinase inhibitors and anti-cd20 antibodies.

Legal Events

Date Code Title Description
FG4A Patent for invention issued
KA4A Patent for invention lapsed due to non-payment of fees (with right of restoration)
MM4A Patent for invention definitely lapsed due to non-payment of fees